C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · IEX Real-Time Price · USD
6.03
-0.22 (-3.52%)
At close: Jul 19, 2024, 4:00 PM
6.17
+0.14 (2.32%)
Pre-market: Jul 22, 2024, 7:24 AM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $414.90 million as of July 22, 2024. Its market cap has increased by 127.97% in one year.
Market Cap
414.90M
Enterprise Value
222.98M
1-Year Change
127.97%
Ranking
Category
Stock Price
$6.03
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $414.90M, a decrease of -46.31%. That is a compound annual growth rate of -15.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 414.90M | 49.03% |
| Dec 29, 2023 | 278.40M | -3.60% |
| Dec 30, 2022 | 288.80M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taysha Gene Therapies | 430.95M |
| Aura Biosciences | 429.54M |
| Health Catalyst | 428.59M |
| Ocugen | 427.21M |
| Korro Bio | 422.57M |
| Editas Medicine | 411.19M |
| Anika Therapeutics | 409.47M |
| Sonida Senior Living | 407.46M |